644 filings
8-K
KALV
KalVista Pharmaceuticals Inc
22 Apr 24
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
4:55pm
4
William Fairey
22 Apr 24
KalVista Pharmaceuticals / William Fairey ownership change
4:35pm
3
William Fairey
22 Apr 24
KalVista Pharmaceuticals / William Fairey ownership change
4:34pm
SC 13D/A
TCG Crossover GP I, LLC
1 Apr 24
KalVista Pharmaceuticals / TCG Crossover GP I ownership change
4:14pm
8-K
KALV
KalVista Pharmaceuticals Inc
11 Mar 24
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
4:37pm
10-Q
2024 Q3
KALV
KalVista Pharmaceuticals Inc
Quarterly report
11 Mar 24
4:26pm
4
KALV
KalVista Pharmaceuticals Inc
8 Mar 24
KalVista Pharmaceuticals / Benjamin L Palleiko ownership change
4:50pm
8-K
KALV
KalVista Pharmaceuticals Inc
7 Mar 24
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
6:38am
SC 13G
Adage Capital Partners GP, L.L.C.
26 Feb 24
KalVista Pharmaceuticals / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
4:35pm
4
VHCP Management EG, LLC
22 Feb 24
KalVista Pharmaceuticals / Bong Y Koh ownership change
4:15pm
SC 13D/A
KALV
KalVista Pharmaceuticals Inc
22 Feb 24
KalVista Pharmaceuticals / Frazier Life Sciences Public Fund ownership change
1:22pm
4
Edward P. Feener
21 Feb 24
KalVista Pharmaceuticals / Edward P. Feener ownership change
9:51pm
4
KALV
KalVista Pharmaceuticals Inc
21 Feb 24
KalVista Pharmaceuticals / Christopher Yea ownership change
9:48pm
4
KALV
KalVista Pharmaceuticals Inc
21 Feb 24
KalVista Pharmaceuticals / Benjamin L Palleiko ownership change
9:46pm
4
KALV
KalVista Pharmaceuticals Inc
21 Feb 24
KalVista Pharmaceuticals / Paul K. Audhya ownership change
9:44pm
4
KALV
KalVista Pharmaceuticals Inc
21 Feb 24
KalVista Pharmaceuticals / Thomas Andrew Crockett ownership change
9:41pm
SC 13D/A
TCG Crossover GP I, LLC
20 Feb 24
KalVista Pharmaceuticals / TCG Crossover GP I ownership change
4:49pm
8-K
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
424B5
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
Prospectus supplement for primary offering
4:29pm
4
Benjamin L Palleiko
16 Feb 24
KalVista Pharmaceuticals / Benjamin L Palleiko ownership change
4:21pm